ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vizient Announces Trends for Providers to Strategize in 2024

Vizient, Inc. announced it has released trends providers should strategize for in 2024. These include payer strategy, ambulatory design considerations, an approach to primary care access and the importance of targeted technology adoption. View 2024: A Year for Bold Bets.

“Where and how healthcare providers invest their resources is a crucial question,” said Bill Woodson, senior principal, Intelligence at Sg2, a Vizient company. “Those decisions will ultimately impact financial performance, market position, and in the end, patient care delivery.”

The trends are projected based on market research and data analysis, including proprietary Sg2 all-payer claims data. Based on the data and in-house expertise, Vizient is advising providers to:

  • Revisit their payer strategy: Medicare Advantage now represents two-thirds of the total Medicare population in some markets and the number of Medicaid enrollees continues to grow. With a high proportion of Medicare and Medicaid enrollees in managed care, providers should have a strategy that proactively addresses total cost of care as a market play.
  • Re-evaluate their ambulatory business model: As the shift from inpatient to outpatient care continues to accelerate, an ambulatory strategy must be designed to meet consumer expectations. Providers should also work to understand their consumer purchasing patterns and get ahead of forthcoming price transparency mandates.
  • Change the game in primary care: Primary care in traditional office settings will shrink to less than 50% of market share by 2030, according to Sg2, as payer-owned and retail healthcare models surge. Analytics can help pinpoint key growth segments. Providers should keep an eye on new-market entrants and use analytics to determine gaps those entrants address before deciding whether to partner or compete.
  • Differentiate through targeted technology adoption: Technology adoption is crucial to effectively managing accelerating consumer needs. Evolving AI tools, home DNA testing, new cellular-based therapies, telehealth visits and use of digital devices that capture real-time health trends all show exponential growth.

“2024 must be a year of inside-out focus for healthcare organizations. Investing time, talent and capital in areas that better meet patient need today and address what tomorrow’s patients will demand is essential,” said Woodson. “A focus on these vital areas will help providers on their journey to cost, quality and market performance alignment.”

Read 2024: A Year for Bold Bets.

About Vizient, Inc.

Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company, serves more than 60% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 25% of the non-acute care market. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient’s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

“2024 must be a year of inside-out focus for healthcare organizations. Investing time, talent and capital in areas that better meet patient need today and address what tomorrow’s patients will demand is essential.”

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.